Moreover, neither expression of Plag1 nor Lin28b was significantly altered following GSK343 treatment of MLL-AF9 tumors, reinforcing the concept of disparity between transcriptional programs repressed by Ezh2 that are responsible for early tumor suppression and later maintenance of these leukemias. This evidence concerns the gene LIN28B and leukemia.